Michael C. Hanley's most recent trade in Enterprise Products Partners L P - Unit was a trade of 100,000 Phantom Units done . Disclosure was reported to the exchange on Dec. 1, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Enterprise Products Partners L P - Unit | Michael C. Hanley | EVP & Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Dec 2025 | 100,000 | 100,000 | - | - | Phantom Units | |
| Alto Neuroscience Inc | Michael Conick Hanley | CHIEF OPERATING OFFICER | Sale or transfer of securities back to the company at price $ 0.00 per share. | 03 Jul 2025 | 188,000 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Alto Neuroscience Inc | Michael Conick Hanley | CHIEF OPERATING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jul 2025 | 188,000 | 188,000 | - | - | Employee Stock Option (Right to Buy) | |
| Alto Neuroscience Inc | Michael Conick Hanley | CHIEF OPERATING OFFICER | Sale or transfer of securities back to the company at price $ 0.00 per share. | 03 Jul 2025 | 125,000 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Alto Neuroscience Inc | Michael Conick Hanley | CHIEF OPERATING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jul 2025 | 125,000 | 125,000 | - | - | Employee Stock Option (Right to Buy) | |
| Alto Neuroscience Inc | Michael Conick Hanley | CHIEF OPERATING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jul 2025 | 8,000 | 8,000 | - | - | Employee Stock Option (Right to Buy) | |
| Alto Neuroscience Inc | Michael Conick Hanley | CHIEF OPERATING OFFICER | Sale or transfer of securities back to the company at price $ 0.00 per share. | 03 Jul 2025 | 8,000 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Alto Neuroscience Inc | Michael Conick Hanley | CHIEF OPERATING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2025 | 125,000 | 125,000 | - | - | Employee Stock Option (Right to Buy) | |
| Alto Neuroscience Inc | Michael Conick Hanley | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2024 | 188,000 | 188,000 | - | - | Employee Stock Option (right to buy) | |
| Aeglea BioTherapeutics Inc | Michael Conick Hanley | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 500,000 | 500,000 | - | - | Employee Stock Option (right to buy) | |
| Aeglea BioTherapeutics Inc | Michael Conick Hanley | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Aug 2022 | 130,000 | 130,000 | - | - | Employee Stock Option (right to buy) | |
| Aeglea BioTherapeutics Inc | Michael Conick Hanley | Chief Commercial Officer | Purchase of securities on an exchange or from another person at price $ 0.71 per share. | 08 Jun 2022 | 28,200 | 36,200 (0%) | 0% | 0.7 | 20,022 | Common Stock |
| Aeglea BioTherapeutics Inc | Michael Conick Hanley | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2022 | 160,000 | 160,000 | - | - | Employee Stock Option (right to buy) | |
| Aeglea BioTherapeutics Inc | Michael Conick Hanley | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2021 | 135,000 | 135,000 | - | - | Employee Stock Option (right to buy) |